Advanced search
Publication Cover
Emerging Microbes & Infections Volume 4, 2015 - Issue 1
Submit an article Journal homepage
2,636
Views
34
CrossRef citations to date
0
Altmetric
Reviews

Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China

Vincent CC ChengDepartment of Microbiology, Queen Mary Hospital, Hong Kong, China;Infection Control Team, Queen Mary Hospital, Hong Kong, China
,
Sally CY WongDepartment of Microbiology, Queen Mary Hospital, Hong Kong, China
,
Pak-Leung HoDepartment of Microbiology, Queen Mary Hospital, Hong Kong, China
&
Kwok-Yung YuenDepartment of Microbiology, Queen Mary Hospital, Hong Kong, China;Department of Clinical Microbiology and Infection Control, Hong Kong University-Shenzhen Hospital, Shenzhen 518053, Guangdong province, ChinaCorrespondence[email protected]
Pages 1-13 | Received 30 Oct 2014, Accepted 30 Dec 2014, Published online: 25 Jan 2019

  • World Health Organization. Antimicrobial resistance: global report on surveillance 2014. Geneva: WHO, 2014. Available at http://www.who.int/drugresistance/documents/surveillancereport/en/ (accessed 27 October 2014).
  • The White House. National Strategy For Combating Antibiotic-Resistant Bacteria. Washington, DC: The White House, 2014. Available at http://www.whitehouse.gov/sites/default/files/docs/carb_national_strategy.pdf (accessed 27 October 2014).
  • D'Costa VM, McGrann KM, Hughes DW, Wright GD.Sampling the antibiotic resistome. Science2006;311: 374–377.
  • Plough HH.Penicillin resistance of Staphylococcus aureus and its clinical implications. Am J Clin Pathol1945;15: 446–451.
  • Livermore DM, Reynolds R, Stephens P et al.Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors. Int J Antimicrob Agents2006;28: 273–279.
  • Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S et al.10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother2013;68: 562–568.
  • Song JH, Hsueh PR, Chung DR et al.Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother2011;66: 1061–1069.
  • Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM.Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA1999;96: 6908–6913.
  • Stephens C, Francis SJ, Abell V, DiPersio JR, Wells P.Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital. Am J Infect Control2007;35: 212–215.
  • Thaden JT, Lewis SS, Hazen KC et al.Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol2014;35: 978–983.
  • Qin S, Fu Y, Zhang Q et al.High incidence and endemic spread of NDM-1-positive Enterobacteriaceae in Henan Province, China. Antimicrob Agents Chemother2014;58: 4275–4282.
  • Wang P, Hu F, Xiong Z et al.Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints. J Clin Microbiol2011;49: 3127–3131.
  • Yang Q, Wang H, Sun H, Chen H, Xu Y, Chen M.Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China. Antimicrob Agents Chemother2010;54: 573–577.
  • Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y.ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother2011;66: 307–312.
  • Ho PL, Lo WU, Yeung MK et al.Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One2011;6: e17989.
  • Ho PL, Li Z, Lai EL, Chiu SS, Cheng VC.Emergence of NDM-1-producing Enterobacteriaceae in China. J Antimicrob Chemother2012;67: 1553–1555.
  • Ho PL, Lo WU, Chan J et al.pIMP-PH114 carrying bla IMP-4 in a Klebsiella pneumoniae strain is closely related to other multidrug-resistant IncA/C2 plasmids. Curr Microbiol2014;68: 227–232.
  • Lo WU, Cheung YY, Lai E, Lung D, Que TL, Ho PL.Complete sequence of an IncN plasmid, pIMP-HZ1, carrying blaIMP-4 in a Klebsiella pneumoniae strain associated with medical travel to China. Antimicrob Agents Chemother2013;57: 1561–1562.
  • Ho PL, Li Z, Lo WU et al.Identification and characterization of a novel incompatibility group X3 plasmid carrying blaNDM-1 in Enterobacteriaceae isolates with epidemiological links to multiple geographical areas in China. Emerg Microbes Infect2012;1: e39.
  • Wang X, Xu X, Li Z et al.An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in mainland China. Microb Drug Resist2014;20: 144–149.
  • Zhao WH, Hu ZQ.IMP-type metallo-beta-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol2011;37: 214–226.
  • Chen Y, Zhou Z, Jiang Y, Yu Y.Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother2011;66: 1255–1259.
  • Ho PL, Chan WM, Tsang KW, Wong SS, Young K.Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes. Scand J Infect Dis2002;34: 567–573.
  • Ho PL, Que TL, Ng TK, Chiu SS, Yung RW, Tsang KW.Clinical outcomes of bacteremic pneumococcal infections in an area with high resistance. Eur J Clin Microbiol Infect Dis2006;25: 323–327.
  • Ho PL, Cheng VC, Chu CM.Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii. Chest2009;136: 1119–1127.
  • Feikin DR, Schuchat A, Kolczak M et al.Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health2000;90: 223–229.
  • Neuman MI, Kelley M, Harper MB, File TMJr, Camargo CAJr.Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia. J Emerg Med2007;32: 349–357.
  • Erdem H, Elaldi N, Oztoprak N et al.Mortality indicators in pneumococcal meningitis: therapeutic implications. Int J Infect Dis2014;19: 13–19.
  • Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E.Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med2005;165: 1375–1380.
  • Tumbarello M, Sanguinetti M, Montuori E et al.Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother2007;51: 1987–1994.
  • Melzer M, Petersen I.Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect2007;55: 254–259.
  • Shurland S, Zhan M, Bradham DD, Roghmann MC.Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol2007;28: 273–279.
  • Wang FD, Chen YY, Chen TL, Liu CY.Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control2008;36: 118–122.
  • Blot SI, Vandewoude KH, Hoste EA, Colardyn FA.Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med2002;162: 2229–2235.
  • Kim SY, Jung JY, Kang YA et al.Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit. J Korean Med Sci2012;27: 939–947.
  • Chang YY, Chuang YC, Siu LK et al.Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect2014 Jul 26.pii: S1684-1182(14)00107-8. doi: 10.1016/j.jmii.2014.05.010. [Epub ahead of print]
  • Quach C, Weiss K, Moore D, Rubin E, McGeer A, Low DE.Clinical aspects and cost of invasive Streptococcus pneumoniae infections in children: resistant vs. susceptible strains. Int J Antimicrob Agents2002;20: 113–118.
  • Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y.Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother2006;50: 1257–1262.
  • Pada SK, Ding Y, Ling ML et al.Economic and clinical impact of nosocomial meticillin-resistant Staphylococcus aureus infections in Singapore: a matched case-control study. J Hosp Infect2011;78: 36–40.
  • Lautenbach E, Weiner MG, Nachamkin I, Bilker WB, Sheridan A, Fishman NO.Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol2006;27: 893–900.
  • Lemos EV, de la Hoz FP, Alvis N et al.Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia. Clin Microbiol Infect2014;20: 174–180.
  • Garlantezec R, Bourigault C, Boles JM et al.Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak. J Hosp Infect2011;77: 174–175.
  • Hu Y, Yang X, Lu N, Zhu B.The abundance of antibiotic resistance genes in human guts has correlation to the consumption of antibiotics in animal. Gut Microbes2014;5: 245–249.
  • Levy SB, FitzGerald GB, Macone AB.Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. N Engl J Med1976;295: 583–588.
  • Aarestrup FM, Bager F, Jensen NE, Madsen M, Meyling A, Wegener HC.Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS1998;106: 606–622.
  • Forslund K, Sunagawa S, Kultima JR et al.Country-specific antibiotic use practices impact the human gut resistome. Genome Res2013;23: 1163–1169.
  • Hvistendahl M.Public health. China takes aim at rampant antibiotic resistance. Science2012;336: 795.
  • Hollis A, Ahmed Z.Preserving antibiotics, rationally. N Engl J Med2013;369: 2474–2476.
  • Xu J, Sun Z, Li Y, Zhou Q.Surveillance and correlation of antibiotic consumption and resistance of Acinetobacter baumannii complex in a tertiary care hospital in northeast China, 2003–2011. Int J Environ Res Public Health2013;10: 1462–1473.
  • Xu J, Duan X, Wu H, Zhou Q.Surveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based study. PLoS One2013;8: e78604.
  • Li Y, Xu J, Wang F et al.Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff (Millwood)2012;31: 1075–1082.
  • Jiang Q, Yu BN, Ying G et al.Outpatient prescription practices in rural township health centers in Sichuan Province, China. BMC Health Serv Res2012;12: 324.
  • Currie J, Lin W, Zhang W.Patient knowledge and antibiotic abuse: evidence from an audit study in China. J Health Econ2011;30: 933–949.
  • Zou S, Xu W, Zhang R, Tang J, Chen Y, Zhang G.Occurrence and distribution of antibiotics in coastal water of the Bohai Bay, China: impacts of river discharge and aquaculture activities. Environ Pollut2011;159: 2913–2920.
  • Chen Y, Zhang H, Luo Y, Song J.Occurrence and dissipation of veterinary antibiotics in two typical swine wastewater treatment systems in east China. Environ Monit Assess2012;184: 2205–2217.
  • Peng X, Zhang K, Tang C, Huang Q, Yu Y, Cui J.Distribution pattern, behavior, and fate of antibacterials in urban aquatic environments in South China. J Environ Monit2011;13: 446–454.
  • Peng X, Tan J, Tang C, Yu Y, Wang Z.Multiresidue determination of fluoroquinolone, sulfonamide, trimethoprim, and chloramphenicol antibiotics in urban waters in China. Environ Toxicol Chem2008;27: 73–79.
  • Minh TB, Leung HW, Loi IH et al.Antibiotics in the Hong Kong metropolitan area: ubiquitous distribution and fate in Victoria Harbour. Mar Pollut Bull2009;58: 1052–1062.
  • Leung HW, Minh TB, Murphy MB et al.Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China. Environ Int2012;42: 1–9.
  • Jiang HX, Song L, Liu J et al.Multiple transmissible genes encoding fluoroquinolone and third-generation cephalosporin resistance co-located in non-typhoidal Salmonella isolated from food-producing animals in China. Int J Antimicrob Agents2014;43: 242–247.
  • Ho PL, Chow KH, Lai EL et al.Extensive dissemination of CTX-M-producing Escherichia coli with multidrug resistance to ‘critically important’ antibiotics among food animals in Hong Kong, 2008–10. J Antimicrob Chemother2011;66: 765–768.
  • Ho PL, Chan J, Lo WU et al.Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals. J Appl Microbiol2013;114: 695–702.
  • Lo WU, Chow KH, Law PY et al.Highly conjugative IncX4 plasmids carrying blaCTX-M in Escherichia coli from humans and food animals. J Med Microbiol2014;63 (Pt 6): 835–840.
  • Ho PL, Wong RC, Chow KH, Que TL.Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals. Lett Appl Microbiol2009;49: 627–634.
  • Ho PL, Wong RC, Lo SW, Chow KH, Wong SS, Que TL.Genetic identity of aminoglycoside-resistance genes in Escherichia coli isolates from human and animal sources. J Med Microbiol2010;59 (Pt 6): 702–707.
  • Ho PL, Lo WU, Yeung MK et al.Dissemination of pHK01-like incompatibility group IncFII plasmids encoding CTX-M-14 in Escherichia coli from human and animal sources. Vet Microbiol2012;158: 172–179.
  • Ho PL, Yeung MK, Lo WU et al.Predominance of pHK01-like incompatibility group FII plasmids encoding CTX-M-14 among extended-spectrum beta-lactamase-producing Escherichia coli in Hong Kong, 1996–2008. Diagn Microbiol Infect Dis2012;73: 182–186.
  • Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, Bager F.Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother2001;45: 2054–2059.
  • Pantosti A, del Grosso M, Tagliabue S, Macri A, Caprioli A.Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban. Lancet1999;354: 741–742.
  • Angulo FJ, Baker NL, Olsen SJ, Anderson A, Barrett TJ.Antimicrobial use in agriculture: controlling the transfer of antimicrobial resistance to humans. Semin Pediatr Infect Dis2004;15: 78–85.
  • Brechet C, Plantin J, Sauget M et al.Wastewater treatment plants release large amounts of extended-spectrum beta-lactamase-producing Escherichia coli into the environment. Clin Infect Dis2014;58: 1658–1665.
  • Slekovec C, Plantin J, Cholley P et al.Tracking down antibiotic-resistant Pseudomonas aeruginosa isolates in a wastewater network. PLoS One2012;7: e49300.
  • Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M.A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis2014;14: 13.
  • van Boeckel TP, Gandra S, Ashok A et al.Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis2014;14: 742–750.
  • Stille CJ, Rifas-Shiman SL, Kleinman K, Kotch JB, Finkelstein JA.Physician responses to a community-level trial promoting judicious antibiotic use. Ann Fam Med2008;6: 206–212.
  • Macovei L, Zurek L.Influx of enterococci and associated antibiotic resistance and virulence genes from ready-to-eat food to the human digestive tract. Appl Environ Microbiol2007;73: 6740–6747.
  • Hamilton-Miller JM, Shah S.Identity and antibiotic susceptibility of enterobacterial flora of salad vegetables. Int J Antimicrob Agents2001;18: 81–83.
  • Ruimy R, Brisabois A, Bernede C et al.Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents. Environ Microbiol2010;12: 608–615.
  • Fischer J, Rodriguez I, Schmoger S et al.Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm. J Antimicrob Chemother2012;67: 1793–1795.
  • Fischer J, Rodriguez I, Schmoger S et al.Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. J Antimicrob Chemother2013;68: 478–480.
  • Poirel L, Bercot B, Millemann Y, Bonnin RA, Pannaux G, Nordmann P.Carbapenemase-producing Acinetobacter spp. in Cattle, France. Emerg Infect Dis2012;18: 523–525.
  • Wang Y, Wu C, Zhang Q et al.Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS One2012;7: e37152.
  • Zhang WJ, Lu Z, Schwarz S et al.Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. J Antimicrob Chemother2013;68: 1681–1682.
  • Prats G, Mirelis B, Miro E et al.Cephalosporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Emerg Infect Dis2003;9: 1273–1280.
  • Lavilla S, Gonzalez-Lopez JJ, Miro E et al.Dissemination of extended-spectrum beta-lactamase-producing bacteria: the food-borne outbreak lesson. J Antimicrob Chemother2008;61: 1244–1251.
  • Depoorter P, Persoons D, Uyttendaele M et al.Assessment of human exposure to 3rd generation cephalosporin resistant E. coli (CREC) through consumption of broiler meat in Belgium. Int J Food Microbiol2012;159: 30–38.
  • Kantele A, Lääveri T, Mero S et al.Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae. Clin Infect Dis2015. In press.
  • Nordgard L, Brusetti L, Raddadi N, Traavik T, Averhoff B, Nielsen KM.An investigation of horizontal transfer of feed introduced DNA to the aerobic microbiota of the gastrointestinal tract of rats. BMC Res Notes2012;5: 170.
  • Nordgard L, Nguyen T, Midtvedt T, Benno Y, Traavik T, Nielsen KM.Lack of detectable DNA uptake by bacterial gut isolates grown in vitro and by Acinetobacter baylyi colonizing rodents in vivo. Environ Biosafety Res2007;6: 149–160.
  • Cheng VC, Chan JF, Wong SC et al.Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area. Chin Med J (Engl)2013;126: 4504–4509.
  • Cheng VC, Tai JW, Chen JH et al.Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. J Formos Med Assoc2014;113: 734–741.
  • Zhang C, Qiu S, Wang Y et al.Higher isolation of NDM-1 producing Acinetobacter baumannii from the sewage of the hospitals in Beijing. PLoS One2013;8: e64857.
  • Walsh TR, Weeks J, Livermore DM, Toleman MA.Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis2011;11: 355–362.
  • Ruppe E, Armand-Lefevre L, Estellat C et al.Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Euro Surveill2014;19: 20768.
  • Cheng VC, Li IW, Wu AK et al.Effect of antibiotics on the bacterial load of meticillin-resistant Staphylococcus aureus colonisation in anterior nares. J Hosp Infect2008;70: 27–34.
  • Cheng VC, Chan JF, To KK, Tai JW, Ho PL.Detection of community-associated MRSA as a result of the unmasking effect of antibiotic treatment. J Hosp Infect2009;72: 273–274.
  • Cheng VC, Wong LM, Tai JW et al.Prevention of nosocomial transmission of norovirus by strategic infection control measures. Infect Control Hosp Epidemiol2011;32: 229–237.
  • Cheng VC, Yam WC, Lam OT et al.Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong. Eur J Clin Microbiol Infect Dis2011;30: 1371–1381.
  • Vandenbroucke-Grauls CM.Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol1996;17: 512–513.
  • Nystrom B.Forty years of control of healthcare-associated infections in Scandinavia. GMS Krankenhhyg Interdiszip2007;2: Doc09.
  • Bode LG, Wertheim HF, Kluytmans JA et al.Sustained low prevalence of meticillin-resistant Staphylococcus aureus upon admission to hospital in The Netherlands. J Hosp Infect2011;79: 198–201.
  • Johnson AP, Davies J, Guy R et al.Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother2012;67: 802–809.
  • Ben-David D, Maor Y, Keller N et al.Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol2010;31: 620–626.
  • Schwaber MJ, Lev B, Israeli A et al.Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis2011;52: 848–855.
  • Cheng VC, Tai JW, Ho SK et al.Introduction of an electronic monitoring system for monitoring compliance with Moments 1 and 4 of the WHO “My 5 Moments for Hand Hygiene” methodology. BMC Infect Dis2011;11: 151.
  • Pittet D.Improving adherence to hand hygiene practice: a multidisciplinary approach. Emerg Infect Dis2001;7: 234–240.
  • Cheng VC, Wu AK, Cheung CH et al.Outbreak of human metapneumovirus infection in psychiatric inpatients: implications for directly observed use of alcohol hand rub in prevention of nosocomial outbreaks. J Hosp Infect2007;67: 336–343.
  • Cheng VC, Tai JW, Ho YY, Chan JF.Successful control of norovirus outbreak in an infirmary with the use of alcohol-based hand rub. J Hosp Infect2009;72: 370–371.
  • Cheng VC, Tai JW, Wong LM et al.Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. J Hosp Infect2010;74: 271–277.
  • Cheng VC, Chan JF, Tai JW et al.Successful control of vancomycin-resistant Enterococcus faecium outbreak in a neurosurgical unit at non-endemic region. Emerg Health Threats J2009;2: e9.
  • Cheng VC, Tai JW, Chan WM et al.Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant Staphylococcus aureus in intensive care unit. BMC Infect Dis2010;10: 263.
  • Cheng VC, Tai JW, Lee WM et al.Infection control preparedness for human infection of influenza A H7N9 in Hong Kong. Infect Control Hosp Epidemiol2014. In press.
  • Cheng VC, Chen JH, Poon RW et al.Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene. Eur J Clin Microbiol Infect Dis2014 Nov 21. doi: 10.1007/s10096-014-2281-x. [Epub ahead of print]
  • Cheng VC, To KK, Li IW et al.Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital. Eur J Clin Microbiol Infect Dis2009;28: 1447–1456.
  • Cheng VC, Chau PH, Lee WM et al.Risk assessment of hospital environment using differential contact and mutual contact counts in relation to the activities of hospital healthcare workers, patients, and visitors. J Hosp Infect2015. In press.
  • Cheng VC, Chan JF, Lau EH et al.Studying the transmission dynamics of meticillin-resistant Staphylococcus aureus in Hong Kong using spa typing. J Hosp Infect2011;79: 206–210.
  • Cheng VC, Tai JW, Chau PH et al.Minimal intervention for controlling nosocomial transmission of methicillin-resistant Staphylococcus aureus in resource limited setting with high endemicity. PLoS One2014;9: e100493.
  • Kohler P, Bregenzer-Witteck A, Rettenmund G, Otterbech S, Schlegel M.MRSA decolonization: success rate, risk factors for failure and optimal duration of follow-up. Infection2013;41: 33–40.
  • Huang SS, Septimus E, Kleinman K et al.Targeted versus universal decolonization to prevent ICU infection. N Engl J Med2013;368: 2255–2265.
  • O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RH.Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis1994;18: 105–109.
  • Chia JK, Nakata MM, Park SS, Lewis RP, McKee B.Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis1995;21: 1520.
  • Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM.Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis1999;29: 361–366.
  • Mondy KE, Shannon W, Mundy LM.Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin Infect Dis2001;33: 473–476.
  • Brossier F, Lefrancois S, Paute J et al.Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility. J Hosp Infect2010;76: 368–369.
  • Szachta P, Ignys I, Cichy W.An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol2011;45: 872–877.
  • Manley KJ, Fraenkel MB, Mayall BC, Power DA.Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust2007;186: 454–457.
  • Vidal M, Forestier C, Charbonnel N, Henard S, Rabaud C, Lesens O.Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol2010;48: 2595–2598.
  • Cheng VC, Chen JH, Tai JW et al.Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature. BMC Infect Dis2014;14: 514.
  • O’Fallon E, Pop-Vicas A, D’Agata E.The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities. J Gerontol A Biol Sci Med Sci2009;64: 138–141.
  • Marchaim D, Chopra T, Bogan C et al.The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control2012;40: 760–765.
  • Cheng VC, Tai JW, Wong ZS et al.Transmission of methicillin-resistant Staphylococcus aureus in the long term care facilities in Hong Kong. BMC Infect Dis2013;13: 205.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.